We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$144M
Cap. Flow %
3.24%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,515
Reduced
1,175
Closed
233
Avg Time Held Equity + Options
4.6 years
Top 10 Avg Time Held Equity + Options
2.7 years
Top 20 Avg Time Held Equity + Options
3.7 years
Avg Time Held Equity only
4.6 years
Top 10 Avg Time Held Equity only
2.7 years
Top 20 Avg Time Held Equity only
3.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 46.84%
2 Technology 15.96%
3 Healthcare 9.75%
4 Financials 7.52%
5 Communication Services 4.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
VPG icon
3451
Vishay Precision Group
VPG
$853M
$48 ﹤0.01%
2
– –
2016 Q4
33 quarters
XSW icon
3452
State Street SPDR S&P Software & Services ETF
XSW
$481M
– –
0
– –
2025 Q1
0 quarters
LAB icon
3453
Standard BioTools
LAB
$258M
$40 ﹤0.01%
37
– –
2024 Q1
4 quarters
RNAC icon
3454
Cartesian Therapeutics
RNAC
$199M
$40 ﹤0.01%
3
– –
2020 Q4
17 quarters
ESRT icon
3455
Empire State Realty Trust
ESRT
$819M
$39 ﹤0.01%
5
-1,914
-100% -$17.2K
2020 Q1
20 quarters
AZUL icon
3456
DELISTED
Azul
AZUL
$36 ﹤0.01%
22
-2,001
-99% -$3.93K
2020 Q1
20 quarters
RNST icon
3457
Renasant Corp
RNST
$3.64B
$36 ﹤0.01%
1
-1
-50% -$36
2023 Q4
5 quarters
MVST icon
3458
Microvast
MVST
$219M
$35 ﹤0.01%
30
– –
2021 Q1
16 quarters
ALUR icon
3459
DELISTED
Allurion Technologies
ALUR
$32 ﹤0.01%
10
– –
2024 Q1
4 quarters
DAWN icon
3460
DELISTED
Day One Biopharmaceuticals
DAWN
$32 ﹤0.01%
4
– –
2024 Q4
1 quarter
IDHQ icon
3461
Invesco S&P International Developed Quality ETF
IDHQ
$1.13B
$30 ﹤0.01%
+1
New +$30
2025 Q1
0 quarters
WES icon
3462
Western Midstream Partners
WES
$18.2B
$30 ﹤0.01%
+1
New +$41
2025 Q1
0 quarters
OTLY icon
3463
Oatly Group
OTLY
$356M
$29 ﹤0.01%
3
-1
-25% -$11
2024 Q3
2 quarters
GRWG icon
3464
GrowGeneration
GRWG
$87.8M
$28 ﹤0.01%
26
– –
2021 Q1
16 quarters
SLDB icon
3465
Solid Biosciences
SLDB
$615M
$26 ﹤0.01%
7
– –
2022 Q1
12 quarters
EDV icon
3466
Vanguard World Funds Extended Duration ETF
EDV
$3.75B
– –
-2,613
Closed -$181K –
BYND icon
3467
Beyond Meat
BYND
$123M
– –
0
– –
2025 Q1
0 quarters
CYH icon
3468
Community Health Systems
CYH
$422M
$24 ﹤0.01%
9
– –
2024 Q2
3 quarters
ONL icon
3469
Orion Office REIT
ONL
$118M
$24 ﹤0.01%
11
+5
+83% +$17
2022 Q1
12 quarters
KBE icon
3470
State Street SPDR S&P Bank ETF
KBE
$1.48B
– –
0
– –
2023 Q3
6 quarters
RENT icon
3471
Rent the Runway
RENT
$61.4M
$22 ﹤0.01%
5
– –
2022 Q4
9 quarters
ECF icon
3472
Ellsworth Growth & Income Fund
ECF
$161M
$19 ﹤0.01%
2
– –
2021 Q1
16 quarters
WHWK icon
3473
Whitehawk Therapeutics
WHWK
$173M
$14 ﹤0.01%
8
– –
2020 Q4
17 quarters
DCTH icon
3474
Delcath Systems
DCTH
$514M
$13 ﹤0.01%
1
– –
2020 Q2
19 quarters
OABI icon
3475
OmniAb
OABI
$688M
$10 ﹤0.01%
4
– –
2022 Q4
9 quarters

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $144M of net new capital in Q1 2025, opening 225 new positions and adding to 1,515 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Miscellaneous at 47% of assets, up from 47% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.